Literature DB >> 19064847

Orbital arteriovenous malformations.

Sunil Warrier1, Venkatesh C Prabhakaran, Alejandra Valenzuela, Tim J Sullivan, Garry Davis, Dinesh Selva.   

Abstract

OBJECTIVE: To present the clinical features, management, and outcomes in a series of patients with orbital arteriovenous malformations (AVMs).
METHODS: Clinical records of patients with orbital AVMs confirmed using angiography were reviewed as a retrospective, noncomparative, interventional case series.
RESULTS: Eight patients (3 women and 5 men) with unilateral AVMs and a mean age of 39 years (median, 36.5 years; range, 26-70 years) were reviewed. Findings existed for an average of 11.2 years before diagnosis and included periocular mass (7 patients, 88%); periocular edema, pulsation/bruit, proptosis, episcleral congestion, and previous trauma (4 patients each, 50%); elevated intraocular pressure (3 patients, 38%); pain and reduced visual acuity (2 patients each, 25%); and restriction of extraocular movements, and diplopia (1 patient each, 12%). All of the patients except 1 underwent surgical resection, with 3 (38%) receiving preoperative embolization of feeder vessels; all of the patients had initial resolution of manifestations after treatment.
CONCLUSIONS: Angiography is essential for diagnosis and for planning the management of orbital AVMs. Treatment depends on patient-specific features and includes observation, embolization, and surgical excision or combined preoperative embolization/excision. Given their vascular nature, the main cause of poor management outcomes is perioperative hemorrhage. Outcomes after a multidisciplinary approach are good, with few recurrences reported at follow-up.

Entities:  

Mesh:

Year:  2008        PMID: 19064847     DOI: 10.1001/archophthalmol.2008.501

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  Orbito-Masticatory Syndrome.

Authors:  Pradeep Mettu; M Tariq Bhatti; Mays A El-Dairi; Evan B Price; Amy Y Lin; Ali Alaraj; Pete Setabutr; Heather E Moss
Journal:  J Neuroophthalmol       Date:  2016-09       Impact factor: 3.042

2.  [Exophthalmus with enlarged epibulbar vessels].

Authors:  K Jahny; S Kösling; S Brandt; R Chapot; R Pförtner; H Thieme; C Meltendorf
Journal:  Ophthalmologe       Date:  2014-10       Impact factor: 1.059

3.  Vascular Steal Syndrome, Optic Neuropathy, and Foreign Body Granuloma Reaction to Onyx-18 Embolization for Congenital Orbito-Facial Vascular Malformation.

Authors:  Catherine Y Liu; Marc A Yonkers; Tiffany S Liu; Don S Minckler; Jeremiah P Tao
Journal:  Ocul Oncol Pathol       Date:  2016-02-09

4.  Combined endovascular and surgical approach for the treatment of palpebral arteriovenous malformations: experience of a single center.

Authors:  F Clarençon; R Blanc; C-J Lin; C Mounayer; O Galatoire; S Morax; J Moret; M Piotin
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

5.  Clinical Assessment and Lesion-Specific Management of Orbital Vascular Malformations.

Authors:  Daniel B Rootman; Stefania B Diniz; Liza M Cohen
Journal:  J Neurol Surg B Skull Base       Date:  2021-03-23

6.  Congenital isolated idiopathic episcleral arteriovenous malformation.

Authors:  Aastha Gandhi; Mayuresh Naik
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-10

7.  Combined approach to management of periocular arteriovenous malformation by interventional radiology and surgical excision.

Authors:  Bipasha Mukherjee; Vathsalya Vijay; Swatee Halbe
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

8.  Ocular infarction following ethanol sclerotherapy of an arteriovenous malformation.

Authors:  Tim Link; Yong Kam; Radwan Ajlan
Journal:  Am J Ophthalmol Case Rep       Date:  2019-04-25

9.  Frontal Arteriovenous Malformation Presenting as Painful Unilateral Conjunctiva Injection.

Authors:  Andrew Harkins; Christine Bassig-Santos; Michael Cirone
Journal:  Clin Pract Cases Emerg Med       Date:  2022-02

10.  Ultrafast Ultrasound Imaging of Ocular Anatomy and Blood Flow.

Authors:  Raksha Urs; Jeffrey A Ketterling; Ronald H Silverman
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.